Report calls for better U.S. efforts to fight counterfeit drugs
(HealthDay)—Aiming to reduce the global threat of counterfeit drugs, a new Institute of Medicine report also recommends changes in the United States that include a mandatory drug-tracking system and tighter ...
Medications
Feb 13, 2013 |
not rated yet |
0
New study reveals racial disparities in chronic pain management
Opioids are frequently prescribed for pain management in noncancer patients, but recommended clinical guidelines for monitoring effectiveness and signs of drug abuse are often not implemented. Alongside well-documented racial ...
Medications
Feb 13, 2013 |
not rated yet |
0
Report: Tracking system needed to fight fake drugs
(AP)—A new report calls for a national drug tracking system to fight the growing problem of fake drugs.
Medications
Feb 13, 2013 |
not rated yet |
0
Estonia tops EU drug overdose deaths list
Officials in Estonia raised the alarm Wednesday after a report into drug use in Europe found that the small Baltic nation had the highest incidence of deaths from drug overdoses in the EU.
Medications
Feb 13, 2013 |
not rated yet |
0
Britain snubs costly Novartis blood cancer drug
British health authorities said on Wednesday they would not recommend Jakavi, a drug produced by Swiss pharmaceutical company Novartis to treat a rare form of blood cancer, deeming it too expensive.
Medications
Feb 13, 2013 |
not rated yet |
0
Synthetic marijuana use linked to kidney damage
(HealthDay)—Synthetic marijuana products, also known as Spice or K2, are potentially very dangerous for the kidneys, new research suggests.
Medications
Feb 12, 2013 |
not rated yet |
0
Opioid prescription is on the increase
More and more opioids are being prescribed for pain relief in Germany. This is the conclusion arrived at by Ingrid Schubert, Peter Ihle, and Rainer Sabatowski, whose study of a sample of inhabitants of the state of Hesse ...
Medications
Feb 12, 2013 |
not rated yet |
0
Most NCDs could be treated with small number of cheap generic drugs and within existing budgets
In the fifth Series paper, researchers led by Professor Hans Hogerzeil from the University of Groningen in the Netherlands say that most NCDs could be treated with a small range of inexpensive, off-patent medicines, and suggest ...
Medications
Feb 11, 2013 |
not rated yet |
0
Pomalyst approved for advanced multiple myeloma
(HealthDay)—Pomalyst (pomalidomide) has been approved by the U.S. Food and Drug Administration to treat cases of multiple myeloma that have not responded to other therapies.
Medications
Feb 09, 2013 |
not rated yet |
0
43 percent reduction in deaths from paracetamol due to smaller pack sizes
The number of deaths and liver transplants due to paracetamol overdoses has significantly reduced thanks to UK legislation to make pack sizes smaller, a paper published today in BMJ suggests.
Medications
Feb 07, 2013 |
not rated yet |
0
For drug makers, new 3-D control opens wealth of options
A team of scientists anchored at Yale University has demonstrated a new, highly versatile approach for quickly assembling drug-like compounds, establishing a broad new route to drug discovery and medical treatment. They report ...
Medications
Feb 07, 2013 |
4 / 5 (1) |
0
|
Flu shot may not work as well for seniors
(HealthDay)—Seniors seem to get a weaker boost to their immune system following a flu shot than young people do, a small study shows.
Medications
Feb 07, 2013 |
not rated yet |
0
Natural products could be as effective as synthetic drugs, although the odds are low
In a first-ever comprehensive study of 124 natural product combinations, a team of researchers from the National University of Singapore (NUS) and Tsinghua University, led by Professor Chen Yu Zong from the Department of ...
Medications
Feb 07, 2013 |
not rated yet |
0
Frequently prescribed drug used in concerning ways with harmful side effects
A popular class of drugs commonly used to treat sleep and mood symptoms continues to be frequently prescribed despite being known to have potentially life-threatening side effects.
Medications
Feb 06, 2013 |
not rated yet |
0
US warns of new fake batch of cancer drug Avastin
The Food and Drug Administration is warning U.S. doctors about another counterfeit version of the cancer drug Avastin, the third case involving the best-selling Roche drug in the past year.
Medications
Feb 06, 2013 |
5 / 5 (1) |
0
